Effective viral vector response to SARS-CoV-2 booster vaccination in a patient with rheumatoid arthritis after initial ineffective response to messenger RNA vaccine.

Baker, Matthew C; Mallajosyula, Vamsee; Davis, Mark M; Boyd, Scott D; Nadeau, Kari C; Robinson, William H

Baker, Matthew C; Mallajosyula, Vamsee; Davis, Mark M; Boyd, Scott D; Nadeau, Kari C; Robinson, William H.

Baker MC; Stanford University, Stanford, CA.
Mallajosyula V; Stanford University, Stanford, CA.
Davis MM; Stanford University, Stanford, CA.
Boyd SD; Stanford University, Stanford, CA.
Nadeau KC; Stanford University, Stanford, CA.
Robinson WH; VA Palo Alto Health Care System, Palo Alto, CA.

Arthritis Rheumatol ; 74(3): 541-542, 2022 03.

Article in English | MEDLINE | ID: covidwho-1630112

Subject(s)

Antibodies, Viral; COVID-19 Vaccines; COVID-19/prevention & control; Aged; Arthritis, Rheumatoid; Humans; Male

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Vaccines / COVID-19 / Antibodies, Viral Type of study: Case report / Experimental Studies Topics: Vaccines Limits: Aged / Humans / Male Language: English Journal: Arthritis Rheumatol Year: 2022 Document Type: Article Affiliation country: Art.41978

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google